Mon, Jan 26, 2015, 8:16 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • blazup13 blazup13 Mar 31, 2011 6:41 PM Flag

    Top reasons why OPTR will get FDA approval...

    Agreed IV Vancomycin is the drug of choice against MRSA infections. Staph Aureus colonizes on the nasopharynx and is often either a respiratory tract or skin pathogen. PO Vancomycin has no effect on the respiratory tract or skin, only superficial layers of the GI system as it is non-absorbable.

    If you misunderstand this, you're missing the main reason why both Vancocin (PO Vancomycin - NOT IV) and Fidaxomicin are supposed to have very low #s of systemic adverse reactions, because they are not absorbed systemically.

    This is also the crux of the liver enzyme/hyperuricemia controversy. If these drugs are not absorbed systemically, then how did they elevate liver enzymes or cause high urate levels in the blood stream? I'm not sure what the details were - I have not been able to find them, simply read the results and not which patients and which number had what.

12.780.0000(0.00%)Oct 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.